Fundraising Fox

Halda Therapeutics

New Haven, US · Founded 2018 · Delaware LLC · 7 known investors

haldatx.com
BiotechMedical Devices

Founders & leadership

SP
Scott PhillipsExecutive
LW
Leyi WangManager
RF
Rebecca FreyManager

Board

TSTim Shannon
Tim Shannonin𝕏ManagerGeneral Partner at Canaan Partners
LRLiam Ratcliffe
Liam RatcliffeManagerInvestor at Access Biotechnology

Investors · 7

Reported raises · per SEC filings

Form D private placements

$197.9M disclosed across 4 rounds · 2019–2024

$126.5MraisedAug 2024 · 20 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Liam RatcliffeDirector
  • Nandita ShangariDirector
  • Tim ShannonExecutive Officer, Director
  • Joe CabralDirector
  • Rebecca FreyDirector
  • Rebecca LuseDirector
  • Arjun GoyalDirector
  • Scott PhillipsExecutive Officer
Offering amount
$126.5M
Amount sold
$126.5M
First sale
Jul 2024
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$24.2MraisedMay 2024 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Liam RatcliffeDirector
  • Rebecca FreyDirector
  • Tim ShannonExecutive Officer, Director
  • Scott PhillipsExecutive Officer
Offering amount
$36M
Amount sold
$24.2M
First sale
May 2024
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$41MraisedDec 2021 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott PhillipsExecutive Officer
  • Tim ShannonExecutive Officer, Director
  • Liam RatcliffeDirector
  • Leyi WangDirector
  • Rebecca FreyDirector
Offering amount
$51M
Amount sold
$41M
First sale
Dec 2021
Incorporated
Limited Liability Company, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$6.3MraisedMar 2019 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott PhillipsExecutive Officer
  • Tim ShannonExecutive Officer, Director
  • Wei ZhaoDirector
Offering amount
$25.1M
Amount sold
$6.3M
First sale
Feb 2019
Incorporated
Limited Liability Company, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Halda Therapeutics went on to found or lead other companies.

Competitors · 3

by search overlap

Companies competing with Halda Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

Who are Halda Therapeutics's investors?
Halda Therapeutics's investors include Access Biotechnology, Canaan Partners, Connecticut Innovations, Frazier Life Sciences, RA Capital, Taiho Ventures, LLC, Vida Ventures.
How much funding has Halda Therapeutics raised?
Halda Therapeutics has disclosed $197.9M raised across 4 rounds.
Where is Halda Therapeutics headquartered?
Halda Therapeutics is headquartered in New Haven, US.